Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 13:38
Evidence Synthesis
EPBIO's 36.6% gross margin accelerated to, up from 20.98%.
The company's .98% marginal operating leverage also accelerated, up from 10.69%. In contrast, .8% revenue growth year-over-year decelerated, down from 64.6%. EPBIO's . The .51 INR close price remained flat.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 36.6 % | 20.98 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 20.98 % | 10.69 | ▲ |
| REVENUE_GROWTH_YOY | 25.8 % | 64.6 | ▼ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 1,500 shares | 606 | ▲ |
| CLOSE_PRICE | 98.51 INR | 98.51 | - |